222 Day Hall
Ithaca, New York
E: VP Research
pharmaceutical industry's R&D process is excruciatingly slow
and staggeringly expensive. Creating a new drug takes approximately
15 years and costs companies upwards of $600 million. With genomics,
proteomics, and structural genomics producing more data and more
drug targets, the drug bottleneck is only worsening. Ithaca-based
Gene Network Sciences (GNS), a leader in systems biology, directly
addresses these issues, accelerating drug discovery by leveraging
'omics data (proteomics, metabolomics, structural genomics) to create
dynamic computer models of living cells.
By using in silico modeling to organize the vast amount of raw data
available today, GNS can help companies to prioritize and validate
drug targets, saving millions of dollars in development costs, and
shortening, by years, the time required to make new drugs.